Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mediastinal lymphoma.

J G Strickler1, P J Kurtin

  • 1Department of Pathology, Mayo Clinic, Rochester, MN 55905.

Seminars in Diagnostic Pathology
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Primary mediastinal lymphomas (ML) include Hodgkin's disease, large cell lymphoma, and lymphoblastic lymphoma. These ML types require differentiation from Castleman's disease, another mediastinal lymphoid proliferation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic amyloidosis from A (AA) to T (ATTR): a review.

Journal of internal medicine·2020
Same author

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Education and imaging. Gastrointestinal: Gastric involvement in disseminated lymphadenopathic Kaposi sarcoma.

Journal of gastroenterology and hepatology·2015
Same author

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma.

Leukemia·2011
Same author

Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets.

Leukemia·2010
Same journal

Update on the molecular pathology of the distinctive giant cell, fibro-osseous and bone forming lesions of the jaws.

Seminars in diagnostic pathology·2026
Same journal

Update on the molecular pathology and classification of odontogenic cysts and tumours.

Seminars in diagnostic pathology·2026
Same journal

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era.

Seminars in diagnostic pathology·2026
Same journal

When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses.

Seminars in diagnostic pathology·2026
Same journal

Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification.

Seminars in diagnostic pathology·2026
Same journal

Recent advances in genetic predisposition to primary testicular tumors.

Seminars in diagnostic pathology·2026
See all related articles

Area of Science:

  • Oncology
  • Pathology
  • Hematology

Background:

  • Malignant lymphoma can manifest in the mediastinum as part of systemic disease or as a primary tumor.
  • Primary mediastinal lymphomas (ML) represent a significant group of thoracic malignancies.

Purpose of the Study:

  • To review the key clinical, morphological, and immunophenotypic characteristics of common primary mediastinal lymphomas.
  • To highlight the importance of distinguishing ML from Castleman's disease.

Main Methods:

  • Review of clinical presentations.
  • Analysis of morphological features.
  • Immunophenotypic characterization.

Main Results:

  • Hodgkin's disease (nodular sclerosis type), large cell lymphoma (sclerosis-associated), and lymphoblastic lymphoma (often with acute lymphoblastic leukemia) are the most frequent primary ML types.

Related Experiment Videos

  • Distinct clinical, morphologic, and immunophenotypic profiles characterize these lymphomas.
  • Castleman's disease shares mediastinal involvement but is a distinct entity.

    • Conclusions:

    • Accurate diagnosis of primary mediastinal lymphomas relies on understanding their specific features.
    • Differential diagnosis is crucial, particularly distinguishing ML from Castleman's disease.